Inotiv Files for Bankruptcy as China Primate Tariffs and US Rules Squeeze Lab-Animal Breeder
Updated
Updated · Bloomberg · Jun 3
Inotiv Files for Bankruptcy as China Primate Tariffs and US Rules Squeeze Lab-Animal Breeder
1 articles · Updated · Bloomberg · Jun 3
Summary
Inotiv sought bankruptcy protection after mounting pressure on its business breeding dogs and importing monkeys for drug experiments.
US restrictions on the company’s canine farm and tariffs on non-human primates raised in China helped drive the filing, according to a court declaration by CFO Beth Taylor.
International competition and a broader US push to reduce animal use in preclinical drug-safety studies further weakened demand and finances.
The collapse highlights how regulatory tightening and shifts in drug-testing practices are straining specialized lab-animal suppliers.